COCRYSTAL PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
COCRYSTAL PHARMA, INC. (COCP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 256.00 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-03-31
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 256.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 925.00K shares, a 0.00% change from fiscal 2018.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 925.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 23.72K shares, a 43.38% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 256.00K shares 10-K · filed 2025-03-31 | ||
| 2024-09-30 | 256.00K shares 10-Q · filed 2024-11-13 | |||
| 2022-09-30 | 158.00K shares 10-Q · filed 2022-11-14 | |||
| 2019-12-31 | 925.00K shares 10-K · filed 2020-03-27 | |||
| 2018-12-31 | 925.00K shares 10-K · filed 2019-04-01 | |||
| 2015-12-31 | 23.72K shares 10-K · filed 2016-03-15 | |||
| 2014-12-31 | 16.54K shares 10-K · filed 2016-03-15 | 16.54M shares 10-K · filed 2015-03-31 | ||
| 2013-12-31 | 229.32K shares 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |